（原标题：小方制药监事会关于公司2025年限制性股票激励计划相关事项的核查意见）
к?????????????????????????????????????meer.s Berger, the Company’s Supervisory Board has nominated Mr. J?rg Gerber and Mr. Stefan Wolf for re-election as members of the Supervisory Board at the Annual General Meeting.
The Company also announced its financial figures for the first nine months of the fiscal year 2022/23 (ended March 31, 2023). Group sales revenue reached �15.318 billion, up 11% on an exchange rate-adjusted basis. Adjusted EBITDA came in at �2.679 billion, with an adjusted EBITDA margin of 17.5%. Net income amounted to �1.148 billion. The order intake was reported at a record level of �20.048 billion, representing growth of 26% on an exchange rate-adjusted basis. Backlog increased to �31.288 billion.
In terms of divisions, the Semiconductor Manufacturing Technology division saw sales grow 22% to �4.189 billion. The Digital Industries division reported sales of �4.049 billion, an increase of 6%. The Industrial Automation division had sales of �2.989 billion, up 12%. Mobility division sales were �2.028 billion, growing 14%. Smart Infrastructure division sales were �2.063 billion, increasing by 16%.
The Company confirmed its outlook for the fiscal year 2022/23, expecting Group sales revenue to grow by around 10% on an exchange rate-adjusted basis, with an adjusted EBITDA margin between 17% and 18%. The Company plans to propose a dividend of �4.50 per share at the Annual General Meeting.
Note: The provided content appears to be corrupted or encoded incorrectly, making accurate extraction difficult. Please ensure the document is properly formatted for better results.
首页
微信公众号
证券之星APP
